Search results
What is the treatment for bullous systemic lupus erythematosus? Dapsone , at a dose of 1.0–1.5 mg/kg/day, is considered the treatment of choice. It is effective in the vast majority of patients and leads to rapid clinical improvement within days or a few weeks.
Cutaneous lupus (skin lupus) can cause irritating and unsightly rashes. Untreated, these rashes can cause long-term damage, such as permanent hair loss, scarring and skin discoloration. Some types of cutaneous lupus can develop into skin cancer.
22 maj 2023 · Bullous systemic lupus erythematosus (BSLE) is a rare manifestation of systemic lupus erythematosus. It has clinical and histological features that may lead to misdiagnosis and delayed treatment of this easily treatable condition.
Some forms of cutaneous lupus erythematosus, such as bullous lupus erythematosus and discoid lupus erythematosus, are particularly associated with skin of colour. Dyspigmentation and scarring are complications of CLE that significantly impact quality of life for patients with skin of colour.
4 sie 2011 · Are corticosteroids and immunosuppressors an efficacious treatment for bullous lupus erythematosus with systemic manifestations?
31 paź 2014 · Bullous systemic lupus erythematosus (BSLE) is an uncommon blistering eruption that can occur in patients with systemic lupus erythematosus (SLE). Between 59 and 85 % of SLE patients will have skin manifestations of their disease, but less than 5 % will develop bullous disease [ 1 – 3 ].
Bullous systemic lupus erythematosus (BSLE) is a rare cutaneous complication of systemic lupus erythematosus (SLE). It is a heterogeneous disease that is caused by autoantibodies to the dermoepidermal junction, mainly type VII collagen.
